| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation
|
Li, Xian
|
|
|
230 |
C |
p. 84-93
|
artikel
|
| 2 |
Assessment of the individual determinants of two fibrinolysis assays, GFC and ECLT in platelet-depleted plasma and derived euglobulin fraction respectively
|
Bareille, Marion
|
|
|
230 |
C |
p. 33-36
|
artikel
|
| 3 |
Breaking down tumor thrombus: Current strategies for medical management
|
Tathireddy, Harsha
|
|
|
230 |
C |
p. 144-151
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
230 |
C |
p. IFC
|
artikel
|
| 5 |
Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials
|
Barco, Stefano
|
|
|
230 |
C |
p. 27-32
|
artikel
|
| 6 |
Factor V Leiden, prothrombin, MTHFR, and PAI-1 gene polymorphisms in patients with arterial disease: A comprehensive systematic-review and meta-analysis
|
Valeriani, Emanuele
|
|
|
230 |
C |
p. 74-83
|
artikel
|
| 7 |
Functional analysis of two abnormal antithrombin proteins with different intracellular kinetics
|
Imai, Yuta
|
|
|
230 |
C |
p. 18-26
|
artikel
|
| 8 |
Hemostatic considerations for gender affirming care
|
Garland, Kathleen
|
|
|
230 |
C |
p. 126-132
|
artikel
|
| 9 |
In vitro effects of Gla-domainless factor Xa analog on procoagulant and fibrinolytic pathways in apixaban-treated plasma and whole blood
|
Terada, Rui
|
|
|
230 |
C |
p. 119-125
|
artikel
|
| 10 |
Plasma protein signatures for high on-treatment platelet reactivity to aspirin and clopidogrel in peripheral artery disease
|
Baidildinova, G.
|
|
|
230 |
C |
p. 105-118
|
artikel
|
| 11 |
Platelets provide robustness of spatial blood coagulation to the variation of initial conditions
|
Balandina, Anna N.
|
|
|
230 |
C |
p. 133-143
|
artikel
|
| 12 |
Prediction of in-hospital bleeding in acutely ill medical patients: External validation of the IMPROVE bleeding risk score
|
Villiger, Rahel
|
|
|
230 |
C |
p. 37-44
|
artikel
|
| 13 |
Predictors of cancer in patients with acute pulmonary embolism
|
Felix, Gonçalo
|
|
|
230 |
C |
p. 11-17
|
artikel
|
| 14 |
Recent advances of oxidative stress in thromboangiitis obliterans: biomolecular mechanisms, biomarkers, sources and clinical applications
|
Chen, Qi
|
|
|
230 |
C |
p. 64-73
|
artikel
|
| 15 |
Regulation of mitochondrial function by hydroquinone derivatives as prevention of platelet activation
|
Fuentes, Eduardo
|
|
|
230 |
C |
p. 55-63
|
artikel
|
| 16 |
ROS-driven structural and functional fibrinogen modifications are reverted by interleukin-6 inhibition in Giant Cell Arteritis
|
Bettiol, Alessandra
|
|
|
230 |
C |
p. 1-10
|
artikel
|
| 17 |
SARS-CoV-2 infection, vaccination and acquired hemophilia: Correspondence
|
Mungmunpuntipantip, Rujittika
|
|
|
230 |
C |
p. 153
|
artikel
|
| 18 |
SARS-CoV-2 infection, vaccination and acquired hemophilia: Reply
|
Franchini, Massimo
|
|
|
230 |
C |
p. 152
|
artikel
|
| 19 |
Thromboembolic and bleeding complications during interruptions and after discontinuation of anticoagulant treatment in patients with atrial fibrillation and active cancer: A daily practice evaluation
|
Chu, Gordon
|
|
|
230 |
C |
p. 98-104
|
artikel
|
| 20 |
Thrombus architecture is influenced by the antiplatelet loading treatment in patients with acute myocardial infarction
|
Harm, Tobias
|
|
|
230 |
C |
p. 45-54
|
artikel
|
| 21 |
Transcriptome analysis suggests a central role for complement and C5aR1 in neutrophil activation in APS
|
Alarabi, Ahmed
|
|
|
230 |
C |
p. 94-97
|
artikel
|
Tijdschrift beschrijving